SEC Form D · filed December 22, 2022
Ribon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Jodie M. Morrison · Cambridge, MADirectorJonathan M. Root · Cambridge, MADirectorEmma M. Reeve · Cambridge, MADirectorCameron M. Wheeler · Cambridge, MADirectorJames M. Audia · Cambridge, MADirectorLaura M. Brass · Cambridge, MADirectorEyal Lifschitz · Or Yehuda, L3DirectorGary Sutton · Cambridge, MAExecTerrence M. Mclean · Jersey City, NJDirectorColin M. Smith · New Canaan, CTDirectorNatare Capital Management LP · GREENWICH, CTDirectorJason M. Jacobs · Ephrata, PADirectorNatare Capital GP LLC · GREENWICH, CTDirectorCraig Bissell · Tallahassee, FLDirectorPaul Brannelly · Cambridge, MAExecPrakash Raman · Cambridge, MAExec · DirectorJeff Goater · Cambridge, MADirectorJason Cavalier · Watertown, MADirectorNancy B. Snyderman, M.D., Facs · Watertown, MADirectorC. A. Merrifield · Watertown, MADirectorW. B. Smith · Watertown, MADirectorJames R. Tobin · Watertown, MADirectorAnthony Taylor · Vancouver, British Columbia, CanadaDirectorEyal Lifschitz · Or Yehuda, L3DirectorPaul Brannelly · Canton, MAExecPrakash Raman · Cambridge, MAExec · DirectorJeff Goater · Cambridge, MADirectorGary Sutton · SAN DIEGO, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗